Commentary on 'Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer' Journal Article
| Author: | Seidman, A. |
| Article Title: | Commentary on 'Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer' |
| Keywords: | survival; treatment outcomes; breast neoplasms -- pathology; antineoplastic agents, combined -- therapeutic use; antibodies, monoclonal -- therapeutic use; neoplasm metastasis -- drug therapy; paclitaxel -- therapeutic use; female |
| Journal Title: | Clinical Breast Cancer |
| Volume: | 1 |
| Issue: | 2 |
| ISSN: | 1526-8209 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2000-07-01 |
| Start Page: | 144 |
| Language: | English |
| ACCESSION: | 106961238 |
| PROVIDER: | EBSCOhost |
| PROVIDER: | cin20 |
| DOI: | 10.1016/S1526-8209(11)70119-7 |
| DOI/URL: | |
| Notes: | See PMID: 11899652 -- Accession Number: 106961238 -- Entry Date: 20020920 -- Revision Date: 20150711 -- Publication Type: Journal Article; commentary -- Original Study: Nicholson BP, Paul DM, Hande KR, Shyr Y, Meshad M, Cohen A, et al -- Paclitaxel, 5-fluorouracil, and leucovorin (TFL) in the treatment of metastatic breast cancer -- (CLIN BREAST CANCER) 2000 Jul; 1 (2): 136-143 -- Journal Subset: Biomedical; Blind Peer Reviewed; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 100898731. -- Source: cin20 |
